| NCT Number | NCT05811975 |
| Lead Sponsor | TCRx Therapeutics Co.Ltd |
| Conditions | TCR-T Cells, Refractory Solid Tumors, Relapsed Solid Tumors |
| Enrollment | 50 participants |
| Start Date | 2023-03-07 |
| Primary Completion | 2026-12-31 (estimated) |
| Study Completion | 2028-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2023-04-13 |